Objective: This study assessed the accuracy, quality, and readability of responses from three leading AI chatbots—ChatGPT-3.5, DeepSeek-V3, and Google Gemini-2.5—on the diagnosis, treatment, and long-term risks of adult hypothyroidism, comparing their outputs with current clinical guidelines. Methods: Two thyroid specialists developed 27 questions based on the Guideline for the Diagnosis and Management of Hypothyroidism in Adults (2017 edition), covering three categories: diagnosis, treatment, and long-term health risks. Responses from each AI model were independently evaluated by two reviewers. Accuracy was rated using a six-point Likert scale, quality using the DISCERN tool and the five-point Likert scale, and readability was assessed by the Flesch Reading Ease (FRE), Flesch–Kincaid Grade Level (FKGL), Gunning Fog Index (GFI),and Simple Measure of Gobbledygook(SMOG). Results: All three AI models demonstrated excellent performance in accuracy (mean score > 4.5) and quality (high-quality rate > 94%). According to the DISCERN tool, no significant difference was observed in the overall information quality among the models. However, Gemini-2.5 generated responses of significantly lower quality for treatment-related questions than for diagnostic inquiries. The content generated by all models was relatively difficult to comprehend (low FRE scores and high FKGL/GFI scores), generally requiring a college-level or higher education for adequate understanding. Conclusion: All three AI chatbots were capable of producing highly accurate and high-quality medical information regarding hypothyroidism, with their responses showing strong consistency with clinical guidelines. This underscores the substantial potential of AI in supporting medical information delivery. However, the consistently high reading difficulty of their outputs may limit their practical utility in patient education. Future research should focus on improving the readability and patient-friendliness of AI outputs—through prompt engineering and multi-round dialogue optimization—while maintaining professional accuracy, to enable broader application of AI in health education.
28 June 2023 in Journal of Multidisciplinary Healthcare
The prevalence of antibody-negative chronic autoimmune thyroiditis (SN-CAT) is increasing. The early diagnosis of SN-CAT can effectively prevent its further development. Thyroid ultrasound can diagnose autoimmune thyroiditis and predict hypothyroidism. Primary hypothyroidism with a hypoechoic pattern suggested by thyroid ultrasound and negative thyroid serum antibodies is the main basis for the diagnosis of SN-CAT. However, for early SN-CAT, only hypoechoic thyroid changes and serological antibodies are currently available. This study explored how to achieve an accurate and early diagnosis of SN-CAT and prevent the development of SN-CAT combined with hypothyroidism. The diagnosis of a hypoechoic thyroid by artificial intelligence is expected to be a breakthrough in the accurate diagnosis of SN-CAT.
Background: Ultrasound-guided vacuum-assisted breast biopsy (VABB) has become the standard minimally invasive procedure for diagnosing and treating benign breast lesions. Despite its widespread adoption, postoperative complications such as bruising, residual tumors, and skin injury remain significant clinical challenges that can impact patient outcomes and satisfaction. Current risk assessment methods lack precision, highlighting the need for more sophisticated predictive tools.Methods: We conducted a multicenter retrospective study analyzing 1,064 VABB procedures performed at three medical centers between 2017 and 2025. Using a comprehensive set of 12 preoperative variables including tumor characteristics and anatomical relationships, we developed and validated six machine learning models. The random forest algorithm demonstrated superior performance in our five-fold cross-validation analysis, with particular strength in predicting postoperative bruising and operative duration.Results: Our predictive model achieved exceptional performance for bruising risk assessment (AUC 0.971, accuracy 96.7%) and moderate surgical duration prediction. SHAP analysis identified three key predictive features: tumor size (mean SHAP value 0.32), blood flow grade (0.28), and distance to pectoralis muscle (0.25). The model maintained strong performance in external validation (AUC 0.945), confirming its generalizability. However, prediction of rare complications like tumor residual showed limited effectiveness (AUC 0.68).Conclusions: This study presents a clinically validated machine learning tool that accurately predicts common VABB complications, particularly postoperative bruising. By incorporating specific anatomical and tumor characteristics into preoperative planning, surgeons can better anticipate and potentially mitigate these adverse outcomes. The model's integration into clinical practice could enhance surgical decision-making and improve patient counseling regarding expected recovery experiences. Clinical Trial Registration: https://www.chictr.org.cn/index.html, identifier ChiCTR2500095736.
Introduction: Breast tumors, predominantly benign, are a global health concern affecting women. Vacuum-assisted biopsysystems (VABB) guided by ultrasound are widely used forminimally invasive resection, but their reliance on surgeon experience and positioning challenges hinder adoption in primary healthcare settings. Existing AI solutions often focus on static ultrasound image analysis, failing to meet real-time surgical demands. Methods: This study presents a real-time positioning system for breast tumor rotational resection based on an optimized YOLOv11n architecture to enhance surgical navigation accuracy. Ultrasound video data from 167 patients (116 for training, 33 for validation, and 18 for testing) were collected to train the model. The model’s architecture was optimized across three major components: backbone, neck, and detection head. Key innovations include integrating MobileNetV4 Inverted Residual Block and MobileNetV4 Universal Inverted Bottleneck Block to reduce model parameters and computational load while improving inference efficiency. Results: Compared with the baseline YOLOv11n, the optimized YOLOv11n+ model achieves a 17.1% reduction in parameters and a 27.0% reduction in FLOPS, increasing mAP50 for cutter slot and tumor detection by 2.1%. Two clinical positioning algorithms (Surgical Method 1 and Surgical Method 2) were developed to accommodate diverse surgical workflows. The system comprises a deep neural network for target recognition and a real-time visualization module, enabling millisecond-level tracking, precise annotation, and intelligent prompts for optimal resection timing. Conclusion: These research findings provide technical support for minimally invasive breast tumor resection, holding the promise of reducing reliance on surgical experience and thereby facilitating the application of this technique in primary healthcare institutions.
Seronegative Hashimoto's thyroiditis is often underdiagnosed due to the lack of antibody markers. Combining ultrasound radiomics with machine learning offers potential for early detection in patients with normal thyroid function. Data from 164 patients with single thyroid lesions and normal thyroid function, treated surgically between 2016 and 2024, were retrospectively collected from four hospitals. Radiomics features were extracted from ultrasound images of non-tumorous hypoechoic areas. Pathological lymphocytic infiltration and hypoechoic ratios were evaluated by senior pathologists and ultrasound physicians. A machine learning model, CCH-NET, was developed using a random forest classifier after feature selection with Least Absolute Shrinkage and Selection Operator (LASSO) regression. The model was trained and tested with an 80:20 split and compared to senior ultrasound physicians. The CCH-NET model achieved a sensitivity of 0.762, specificity of 0.714, and an area under the curve (AUC) of 0.8248, outperforming senior ultrasound physicians (AUC = 0.681). It maintained consistent accuracy across test sets, with F1 scores of 0.778 and 0.720 in Test_1 and Test_2, respectively, and exhibited superior predictive rates. The CCH-NET model enhances accuracy in detecting early Seronegative Hashimoto's thyroiditis over senior ultrasound physicians. No. [2023] H013 Chinese Clinical Trial Registry;CTR2400092179; 12 November 2024.